newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager")), announced today the appointment of Rick